Neugranin

Neugranin · Teva Branded Pharmaceutical Products R&D, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Neugranin, covering 2023-02-03 to 2023-03-28. Get the full timeline:

Most recent: Clinical Trial Update: Neugranin in Breast Cancer Participants Receiving Doxorubicin/Docetaxel [Phase 3]